JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ALGS - Aligos Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary ALGS Stock
Financials
Financials ALGS Stock
Loading...
Loading...
Income Statement
Income Statement ALGS Stock
Balance Sheet
Balance Sheet ALGS Stock
Cash Flow Statement
Cash Flow Statement ALGS Stock
Loading...
Loading...
Home
Stocks
Aligos Therapeutics, Inc. (ALGS)
Financials
Financials of ALGS
Loading...
Loading...
ALGS Financials - Aligos Therapeutics Income & Cash Flow | Ledgeburg
Loading...
Loading...
Revenue
$2.186M
Operating Income
$-87.985M
Net Income
$-24.193M
Share Count (Basic)
9.884955M
Operating Cash Flow
$-82.503M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$77.844M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
2M
4M
6M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
1M
2M
3M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-140M
-120M
-100M
-80M
-60M
-40M
-20M
Annual
Quarterly
Margins
Gross
Operating
Net
-4000%
-3000%
-2000%
-1000%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-20M
0
20M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-10000%
-5000%
0%
5000%
10000%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26